March 9 (Reuters) - The U.S. health regulator issued a draft guidance on Monday to help drugmakers develop cheaper versions ...

The Trump administration launched a drug pricing initiative offering immediate savings, but experts debated whether lower ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

The U.S. Food and Drug Administration today announced another major step in its initiative to streamline the development of biosimilar medicines, ...

Many diseases in animals go untreated because of high development costs and limited markets, according to a federal report. Goats and sheep, for example, lack approved drugs to treat parasites. The ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Ron Lanton, Senior Partner & Global Strategist, Lanton, Lanton & Sosa Law PLLC, discusses FDA’s removal of the two-trial requirement marking a significant policy shift and prompting sponsors to ...

March 10, 2026 / Today Technomark Life Sciences ( and MAX BioPharma ( announced their collaboration in the development of MAX BioPharma's oxysterol drug candidate, Oxy210, for targeting ...

The 'Most Favored Nation' policy proposes tying U.S. drug prices to those in foreign countries to lower costs. The author argues this policy could reduce patient access to care and slow medical ...

Semaglutide has already become more than just a “vanity drug.” Clinical trials like SUSTAIN-6 and FLOW have shown it can slash the risk of kidney disease, reduce major heart attacks, and even lower ...

A burdensome regulatory environment is pushing clinical trials overseas. Jacob Becraft is the co-founder and CEO of Strand Therapeutics.

Biologic drugs made up only 5% of prescriptions in the US last year, but accounted for 51% of total drug spending, with many products costing hundreds of thousands of dollars per year. Moreover, only ...